L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors
10.3389/fphar.2020.00425 Summary Keywords acute kidney injury, chuan huang fang, chronic kidney disease, renal fibrosis, reduced glutathione, traditional Chinese medicine Citation Chen L, Ye Z, Wang D, Liu J, Wang Q, Wang C, Xu B and Gong X (2022) Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 12) on chronic kidney disease (stages 24): A multicenter randomized controlled clinical trial
From a regulatory viewpoint, most NGPs lack a history of safe use and therefore do not qualify for existing generic safety designations, such as GRAS or QPS (402)
Diabetes care 27, 10471053
Rather than being derived from pharmaceutical companies or synthesized purely for experimental purposes, it was modeled on a protective compound that the human body produces naturally